Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy and is associated with a number of potential outcomes, including impaired diastolic function, heart failure, and sudden cardiac death. Various etiologies have been described for HCM, including pressure overload and mu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Sasagawa, Shota, Nishimura, Yuhei, Okabe, Shiko, Murakami, Soichiro, Ashikawa, Yoshifumi, Yuge, Mizuki, Kawaguchi, Koki, Kawase, Reiko, Okamoto, Ryuji, Ito, Masaaki, Tanaka, Toshio
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2016
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905960/
https://ncbi.nlm.nih.gov/pubmed/27378925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados